SEOUL, May 16 (Korea Bizwire) – In 2009, Samsung Electronics introduced a “Master” program to help the company’s top researchers to make focused progress in their respective fields, and the initiative is now being adopted by other Samsung affiliates. Prior to the program, senior researchers would have to take on general management roles when they [...]
SEOUL, Apr. 26 (Korea Bizwire) — The application of patents for social robots that can interact and communicate with humans has risen sharply in South Korea in recent years with the advances being made in robotics and artificial intelligence, government data showed Tuesday. Social robot patent applications have surged more than 20 percent annually since [...]
SEOUL, Apr. 12 (Korea Bizwire) — South Korea is set to release a set of support measures, including nurturing talented manpower, to help local pharmaceutical companies make further inroads into the global market, the country’s health minister said Tuesday. The remarks were made during a meeting attended by Health Minister Chung Chin-yeob, and executives of [...]
SEOUL, April 2 (Korea Bizwire) – Samsung Electronics Co., the world’s largest manufacturer of smartphones, slightly reduced its expenditures on research and development (R&D) projects last year, data showed Wednesday, as it sought to acquire key technologies through mergers and acquisitions, data showed Sunday. Samsung Electronics Co. spent 14.79 trillion won (US$13.2 billion) on R&D [...]
SEOUL, March 27 (Korea Bizwire) – South Korea will establish a 113.5 billion-won (US$101.8 million) fund to nurture startups and venture firms in the bio sector to secure new growth engines, the science ministry said Monday. Under the comprehensive plan finalized during a government meeting presided over by Acting President and Prime Minister Hwang Kyo-ahn, [...]
SEOUL, March 21 (Korea Bizwire) – Major South Korean pharmaceutical companies are poised to expand their spending on research and development (R&D) this year despite weak earnings, industry sources said Tuesday. The four drug companies — Hanmi Pharmaceutical Co., Green Cross Corp., Daewoong Pharma and Chong Kun Dang Pharmaceutical Corp. — whose annual R&D spending [...]
SEOUL, Mar. 15 (Korea Bizwire) — The government unveiled its research and development (R&D) plan for next year on Tuesday to secure a new growth strategy to cope with the fast-paced industrial transformation going forward. Under the road map crafted by the Ministry of Science, ICT and Future Planning, the government will increase R&D productivity [...]
SEOUL, March 3 (Korea Bizwire) – South Korea should reduce its reliance on the U.S. economy and push to galvanize domestic demand as the world’s No. 1 economy is expected to continue its slow growth down the road, a state think tank said Friday. In a report on the future of the U.S. economy, the [...]
SEOUL, Feb. 20 (Korea Bizwire) – Less than one in five South Korean manufacturers of medical supplies and equipment said they plan to increase new research and development (R&D) jobs, a survey showed Monday, despite the government’s push to become a global biotech and medical industry hub. According to the survey by the Korea Medical [...]
SEOUL, Feb. 14 (Korea Bizwire) – Four major South Korean pharmaceutical companies spent more than 100 billion won (US$86.9 million) each on research and development (R&D) in 2016, industry officials said Tuesday. The four drug companies — Hanmi Pharmaceutical Co., Green Cross Corp., Daewoong Pharma and Chong Kun Dang Pharmaceutical Corp. — sharply expanded their [...]